Under ASC606, collaboration revenue is recognized as a company incurs costs to deliver the performance obligation....

When starting to assess whether your biotech collaboration falls under ASC 606, you first must determine whether the...

Publicly-traded biotech companies were required to adopt ASC 606 for their revenue recognition in their 2018 financial...

I recently was interviewed by Blake Oliver, co-host of the Cloud Accounting Podcast, on how ASC606 has impacted biotech...

ASC 606 has made understanding revenue recognition patterns more complicated. Having an understanding of the model...

Setting up a biotech chart of accounts

by Paul Giese on Aug 8, 2018 9:18:00 AM

One of the first accounting decisions made by an early-stage biotech is how the chart of accounts is structured. The...

A smooth accounting close is critical to producing financial statements efficiently and effectively. Public companies who...

Upgrade your ERP | Pre- or Post-IPO?

by Paul Giese on Jul 2, 2018 8:02:00 AM

Almost all biotech startups use Quickbooks as their initial enterprise resource planning (ERP) software. With good reason...

Interpreting the revenue recognition accounting guidance for your biotech collaboration is challenging if you aren't a...

Build better financial reports in Excel

by Paul Giese on Jun 22, 2018 8:00:00 AM

Excel is a powerful tool. Almost every small company uses Excel to track budgets, forecasts and long range plans. But,...